Purpose: COPD has large impact on patient morbidity and mortality worldwide. Acute exacerbations (AECOPD) are mostly triggered by respiratory infections including influenza. While corticosteroids are strongly recommended in AECOPD, they are potentially harmful during influenza. We aimed to evaluate if steroid treatment for AECOPD due to influenza may worsen outcomes.
Methods: A retrospective analysis of a Swiss nation-wide hospitalization database was conducted identifying all AECOPD hospitalisations between 2012 and 2017. In separate analyses, outcomes concerning length-of-stay (LOS), in-hospital mortality, rehospitalisation rate, empyema and aspergillosis were compared between AECOPD during and outside influenza season; AECOPD with and without laboratory-confirmed influenza; and AECOPD plus pneumonia with and without laboratory-confirmed influenza.
Results: Patients hospitalized for AECOPD during influenza season showed shorter LOS (11.3 vs. 11.6 day, p < 0.001) but higher rehospitalisation rates (33 vs 31%, p < 0.001) compared to those hospitalized outside influenza season. Patients with confirmed influenza infection had lower in-hospital mortality (3.3 vs. 5.5%, p = 0.010) and rehospitalisation rates (29 vs. 37%, p < 0.001) than those without confirmed influenza.
Conclusion: Using different indicators for influenza as the likely cause of AECOPD, we found no consistent evidence of worse outcomes of AECOPD due to influenza for hospitalized patients. Assuming that most of these patients received corticosteroids, as it is accepted standard of care in Switzerland, this study gives no evidence to change the current practice of using corticosteroids for hospitalized AECOPD independent of the influenza status.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799421 | PMC |
| http://dx.doi.org/10.1007/s15010-021-01743-1 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Clinical significance of various pathogens identified in patients with acute exacerbations of COPD: a multi-center study in South Korea.
Tuberc Respir Dis (Seoul)
December 2024
Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
Background: Respiratory infection is a major cause of acute exacerbation of chronic obstructive pulmonary disease (AECOPD). We investigated the presence of bacterial and viral pathogens and clinical features in patients with AECOPD.
Methods: This retrospective study included 1,186 patients diagnosed with AECOPD from 28 hospitals in South Korea between 2015-2018.
Association between acute exacerbation of chronic obstructive pulmonary disease and short-term exposure to ambient air pollutants in France.
Environ Health
November 2024
Department of Respiratory Disease and Critical Care Unit, University Hospital Center, Amiens-Picardie. 1, Rue du Professeur Christian Cabrol, Amiens-Cedex, 80054, France.
Article Synopsis
- Ambient air pollution is a significant risk factor for chronic obstructive pulmonary disease (COPD), which is a leading cause of death globally, and this study investigated the link between daily air pollutant levels and emergency room visits for acute COPD exacerbations.
- The research was conducted in Amiens, France, in 2017, analyzing 240 emergency room visits among 168 COPD patients and focusing specifically on pollutants like nitrogen dioxide, ozone, and particulate matter, while accounting for other factors like temperature and pollen allergies.
- The results showed a notable correlation between daily emergency visits and particulate matter concentrations, while long-term exposure to air pollutants did not show a consistent link to more frequent COPD exacerbations.
Therapeutic effects of Lianhua Qingke on COPD and influenza virus-induced exacerbation of COPD are associated with the inhibition of NF-κB signaling and NLRP3 inflammasome responses.
Int Immunopharmacol
December 2024
State Key Laboratory for Innovation and Transformation of Luobing Theory, Shijiazhuang Hebei 050035, China; Hebei Academy of Integrated Traditional Chinese and Western Medicine, Hebei 050035, China. Electronic address:
Article Synopsis
- Lianhua Qingke (LHQK) is a traditional Chinese medicine that shows promise in treating respiratory diseases, particularly by reducing inflammation and improving airway health.
- The study used mouse models to test LHQK's effectiveness against chronic obstructive pulmonary disease (COPD) and acute exacerbations caused by virus infections.
- Results indicated that LHQK significantly enhanced lung function, reduced inflammation, and inhibited viral replication, while also affecting key signaling pathways in the body, indicating its potential as a treatment for COPD and related conditions.
Microbiome-host interactions in the pathogenesis of acute exacerbation of chronic obstructive pulmonary disease.
Front Cell Infect Microbiol
August 2024
Department of Respiratory and Critical Care Medicine, Huaian Clinical College of Xuzhou Medical University, Huaian, China.
Objective: To explore the underlying mechanisms the airway microbiome contributes to Acute Exacerbation of Chronic Obstructive Pulmonary Disease(AECOPD).
Methods: We enrolled 31 AECOPD patients and 26 stable COPD patients, their sputum samples were collected for metagenomic and RNA sequencing, and then subjected to bioinformatic analyses. The expression of host genes was validated by Quantitative Real-time PCR(qPCR) using the same batch of specimens.
A metagenomic next-generation sequencing (mNGS)-based analysis of bronchoalveolar lavage samples in patients with an acute exacerbation of chronic obstructive pulmonary disease.
J Mol Histol
October 2024
Department of Respiratory Medicine, Shaanxi Provincial People's Hospital, NO.256, Friendship West Road, Beilin District, Xi'an, 710068, Shaanxi, China.
The role of the bronchoalveolar lavage fluid (BALF) microbiome in acute exacerbations of chronic obstructive pulmonary disease (AECOPD) remains unclear. The advent of the metagenomic next-generation sequencing (mNGS) has made it possible to reveal the complex microbiome composition of the respiratory tract. This study aimed to explore whether there are differences in the BALF microbiome of AECOPD patients with different lung functions.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!